Boston Scientific Satellite Symposium at HFA 2019:
Does Multi-Sensor Prediction Of Heart Failure Facilitate CRT Optimisation?

CFR Journal

HFA 2019: Management of iron deficiency in heart failure: implementing best practices to improve patient outcomes
HFA 2019: Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy
Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress: Resolving dilemmas in the treatment of heart failure
Experts on the Spot: Your questions on dilemmas in the treatment of heart failure answered
Novartis Sponsored Satellite Symposium at EuroPrevent 2018 entitled:
Inflammation in Atherosclerosis: Translating Science into Practicable Solutions
  • ULF landmesser introduction
  • Inflammation in Atherosclerosis
  • Clinical residual cardiovascular risk
  • Advancing standard of care in post-MI patients with elevated HsCRP
  • Summary and Closure
© 2018 Novartis Pharma AG, CH-4002 Basel | April 2018 | GLCM/ATH/0331k